|
Free Research Articles
Citations 51-60 of 789 total displayed.
|
Past content
(since May 2004):
|
Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?
- Julio Delgado, Donald W. Milligan, and Peter Dreger
Blood 2009; 114: 2581-2588.
[Abstract]
[Full text]
[PDF]
Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib
- Richard D. Press, Stephanie G. Willis, Jennifer Laudadio, Michael J. Mauro, and Michael W. N. Deininger
Blood 2009; 114: 2598-2605.
[Abstract]
[Full text]
[PDF]
Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose
- Michael A. Pulsipher, Pintip Chitphakdithai, Brent R. Logan, Susan F. Leitman, Paolo Anderlini, John P. Klein, Mary M. Horowitz, John P. Miller, Roberta J. King, and Dennis L. Confer
Blood 2009; 114: 2606-2616.
[Abstract]
[Full text]
[PDF]
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
- Cheng E. Chee, Shaji Kumar, Dirk R. Larson, Robert A. Kyle, Angela Dispenzieri, Morie A. Gertz, Colin L. Colby, and S. Vincent Rajkumar
Blood 2009; 114: 2617-2618.
[Abstract]
[Full text]
[PDF]
The Duffy-null state is associated with a survival advantage in leukopenic HIV-infected persons of African ancestry
- Hemant Kulkarni, Vincent C. Marconi, Weijing He, Michael L. Landrum, Jason F. Okulicz, Judith Delmar, Dickran Kazandjian, John Castiblanco, Seema S. Ahuja, Edwina J. Wright, Robin A. Weiss, Robert A. Clark, Matthew J. Dolan, and Sunil K. Ahuja
Blood 2009; 114: 2783-2792.
[Abstract]
[Full text]
[PDF]
How I treat Waldenström macroglobulinemia
- Steven P. Treon
Blood 2009; 114: 2375-2385.
[Abstract]
[Full text]
[PDF]
Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome
- Sabine Kayser, Richard F. Schlenk, Martina Correa Londono, Frank Breitenbuecher, Kerstin Wittke, Juan Du, Silja Groner, Daniela Späth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Thomas Fischer, Konstanze Döhner, and for the German-Austrian AML Study Group (AMLSG)
Blood 2009; 114: 2386-2392.
[Abstract]
[Full text]
[PDF]
Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)
- Peter L. Greenberg, Zhuoxin Sun, Kenneth B. Miller, John M. Bennett, Martin S. Tallman, Gordon Dewald, Elisabeth Paietta, Richard van der Jagt, Jessie Houston, Mary L. Thomas, David Cella, and Jacob M. Rowe
Blood 2009; 114: 2393-2400.
[Abstract]
[Full text]
[PDF]
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott, Martin Zimmermann, Todd A. Alonzo, Anne Auvrignon, H. Berna Beverloo, Myron Chang, Ursula Creutzig, Michael N. Dworzak, Erik Forestier, Brenda Gibson, Henrik Hasle, Christine J. Harrison, Nyla A. Heerema, Gertjan J. L. Kaspers, Anna Leszl, Nathalia Litvinko, Luca Lo Nigro, Akira Morimoto, Christine Perot, Rob Pieters, Dirk Reinhardt, Jeffrey E. Rubnitz, Franklin O. Smith, Jan Stary, Irina Stasevich, Sabine Strehl, Takashi Taga, Daisuke Tomizawa, David Webb, Zuzana Zemanova, C. Michel Zwaan, and Marry M. van den Heuvel-Eibrink
Blood 2009; 114: 2489-2496.
[Abstract]
[Full text]
[PDF]
Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures
- Robert E. Donahue, Ping Jin, Aylin C. Bonifacino, Mark E. Metzger, Jiaqiang Ren, Ena Wang, and David F. Stroncek
Blood 2009; 114: 2530-2541.
[Abstract]
[Full text]
[PDF]
|
|
